Çagla Tükel, PhD, Associate Professor of Microbiology and Immunology at the Lewis Katz School of Medicine at Temple University, offered insight to Contagion Live about a new study showing a first-of-its-kind therapeutic molecule, a type of monoclonal antibody, holds promise in breaking apart communities of harmful bacteria known as biofilms to open the way for antibiotics. These biofilms are notorious for forming on implanted medical devices and on tissues in the body. Dr. Tükel was the senior author on the study, which was published in the journal Nature Communications.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
Major Advances in Treating Lung Blood Clots Could Eliminate Need for ICU Stay, According to New Research at the Lewis Katz School of Medicine at Temple University
Posted November 22, 2024A novel “on-the-table” therapeutic strategy with a total procedure time of less than one hour can safely reduce the size of blood clots lodged in the pulmonary arteries and eliminate the need for post-procedural drug infusion in an intensive care unit, according to Katz School of Medicine research.
Read MoreHealio Highlights Dr. Kristin Criner’s Session at the GOLD International COPD Conference
Posted November 21, 2024Healio highlighted the key takeaways from Dr. Criner’s session on how to identify and treat patients with COPD plus diabetes or osteoporosis.
Read More